26/10/2024
The recent recall initiated by the Food and Drug Administration (FDA) has raised important concerns regarding the antidepressant duloxetine, commonly known by its brand name, Cymbalta. This recall affects over 7,000 bottles of the medication due to the detection of nitrosamines, specifically a compound called N-nitroso-duloxetine, which is known to pose a cancer risk. !( Key Takeaways The FDA has issued a recall notice for more than 7,000 bottles of duloxetine, which are used to treat depression, anxiety, and nerve pain....
The recent recall initiated by the Food and Drug Administration (FDA) has raised important concerns regarding the antidepressant duloxetine, commonly known by its brand name, Cymbalta. This recall …